At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
Aurora Endometrial Ablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Two-Phase Clinical Study of the Minerva AURORA Ablation System
In Brief
A clinical study evaluating Aurora Endometrial Ablation System for Menorrhagia Due to Benign Causes. Completed, enrolled 23 participants across 3 sites.
Detailed Summary
The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events will be assessed along with an assessment of the reduction of uterine bleeding as measured by a pictorial blood loss assessment chart (PBLAC) or menstrual diary.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMenorrhagia Due to Benign Causes
CountriesHungary
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
Primary CompletionNov 2012
First PostedJan 2014
Study CompletionFeb 2015
TodayJul 2026
First PostedJan 14, 2014
Enrollment StartMay 1, 2011
Primary CompletionNov 1, 2012
Study CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.5 years ago
Interventions
Aurora Endometrial Ablation Systemdevice
Ablation of the endometrial lining of the uterus using the Aurora System